Trial intelligence / Profile preview

Effect of ciprofol on ventricular function in children with congenital heart disease

ChiCTR2300070088Phase 4Not yet recruiting

Sponsor
Shanghai Children's Medical Center
Start
Apr 2023
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in Cardiovascular Malformation (CVM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: ventricular strain. Planned start Apr 2023; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ChiCTR2300070088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300070088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call